Health Journal Online

Tag: mpox

  • New York City Reports First Severe Mpox Clade I Case — A More Dangerous Strain Now Showing Up Across America

    New York City Reports First Severe Mpox Clade I Case — A More Dangerous Strain Now Showing Up Across America

    New York City has confirmed its first case of mpox caused by clade I — the more dangerous variant of the virus — raising concern among public health officials as the more infectious and more severe form of mpox continues to arrive in major U.S. cities. The NYC Health Department issued a formal advisory noting that there is no known local community transmission tied to this case, but health commissioner Dr. Alister Martin confirmed the virus is now present in the city and urged residents to be aware of symptoms and vaccination options.

    As of May 9, 2026, the NYC Department of Health reported 79 mpox cases in New York City in 2026 alone, including at least a small number of clade I cases. Nationally, the CDC confirmed more than 20 clade I mpox cases in the United States as of June 2026, all linked to recent international travel or contact with travelers from affected regions in Central and Eastern Africa or Western Europe.

    Clade I vs. Clade II: Why This Strain Is More Concerning

    Most Americans became familiar with mpox during the 2022 global outbreak, which was caused by clade II — a less severe form of the virus with a survival rate above 99.9%. Clade I is different. According to Fox News senior medical analyst Dr. Marc Siegel, “Clade I causes more severe symptoms and can be life-threatening.” In the ongoing outbreak in the Democratic Republic of the Congo, clade I has had a case fatality rate significantly higher than clade II. Complications can include severe skin lesions, pneumonia, brain inflammation, and bacterial superinfections.

    While clade I spreads through the same routes as clade II — primarily close physical contact, sexual contact, kissing, and contact with infected skin lesions or respiratory droplets at close range — it does not spread through casual airborne contact over long distances. The CDC has assessed the current risk to the general U.S. population as low, but characterizes the risk as low to moderate for men who have sex with men, who accounted for the majority of the 2022 U.S. outbreak.

    Who Should Get Vaccinated and What to Watch For

    The JYNNEOS vaccine, approved for mpox prevention, provides strong protection against both clade I and clade II. The CDC recommends the two-dose vaccine series for gay, bisexual, and other men who have sex with men aged 18 and older with specific risk factors. Anyone who traveled to or had contact with someone from the DRC, neighboring African countries, or parts of Western Europe reporting clade I cases should consult their healthcare provider immediately.

    Symptoms of mpox typically appear 3 to 17 days after exposure and begin with fever, swollen lymph nodes, muscle aches, and exhaustion, followed by a distinctive rash that progresses through several stages of fluid-filled lesions. Anyone with a new or unexplained rash — particularly after recent travel or close physical contact — should contact a healthcare provider, mention any travel history, and avoid close contact with others until evaluated. NYC offers free mpox vaccination at multiple locations across the five boroughs.

    The arrival of clade I mpox in New York City — the nation’s most densely populated metro area — is a reminder that the city’s international connectivity, while a source of enormous economic and cultural vitality, also serves as an entry point for emerging infectious diseases. Whether the public health infrastructure put in place after 2022 remains fully operational under reduced federal staffing is a question officials have not fully answered.

    Source link

  • New Mpox Signs and How to Spot the Contagious Rash

    New Mpox Signs and How to Spot the Contagious Rash

    Monkeypox, now more commonly referred to as mpox, remains a significant public health concern in 2026 due to evolving knowledge about its symptoms and transmission patterns. This article provides an updated and comprehensive overview of monkeypox symptoms, signs, and the contagious rash associated with the virus. Understanding the latest developments in symptom presentation is crucial for timely recognition and prevention strategies.

    What Are the Common Monkeypox Symptoms in 2026?

    Monkeypox symptoms often begin within 3 to 21 days after exposure to the virus. Early signs typically resemble flu-like symptoms such as fever, headache, muscle aches, chills, exhaustion, and swollen lymph nodes, which are a distinctive feature of mpox compared to similar illnesses. Fatigue and back pain may also occur during this phase. After these initial symptoms, a contagious rash usually appears within 2 to 4 days.

    The rash may start as flat red spots and progress to raised bumps, pustules filled with fluid, and eventually crust over and fall off as scabs. The rash commonly appears on the face, hands, feet, genitals, anus, and sometimes inside the mouth, according to the World Health Organization. The entire symptom duration often lasts 2 to 4 weeks, although immunocompromised individuals may experience a prolonged course.​

    How Does the Mpox Rash Present and Why Is It Contagious?

    The contagious rash is a hallmark of monkeypox infection and is characterized by multiple stages. It begins as macules, flat, discolored spots, then evolves into papules (raised lesions), vesicles (small fluid-filled blisters), pustules (pus-filled blisters), and finally crusts that dry up and fall off after healing. The rash can be itchy or painful and may appear in clusters or spread widely over the body.

    Its appearance can be similar to other viral rashes such as chickenpox or herpes, which sometimes complicates diagnosis. The contagiousness of the rash arises from direct contact with the lesions or the fluid inside the blisters, as well as through respiratory droplets and contaminated materials like bedding or clothing. Proper isolation and hygiene measures are essential to prevent spread during the rash stage.​

    Are There Any New Mpox Signs to Watch For in 2026?

    Recent observations in 2026 highlight some variations in monkeypox symptomatology. While classic symptoms such as fever, swollen lymph nodes, and rash remain predominant, there is an increased reporting of rectal pain or proctitis in some patients without an initial visible rash.

    Ulcers or lesions in the mouth and genital area have also been noted more frequently, which suggests potential new clinical presentations to be aware of. Additionally, some mpox cases involve milder symptoms without the typical widespread rash, making awareness of subtle mpox signs, including localized lesions, important for early diagnosis and intervention.​

    How Long Are Mpox Symptoms and Rash Contagious?

    The mpox incubation period ranges from 3 to 21 days, during which a person is not contagious. Contagiousness begins with the onset of symptoms, particularly once the rash develops. The rash remains contagious until all scabs have fallen off and the skin underneath has healed completely, which typically takes 2 to 4 weeks, as per the Centers for Disease Control and Prevention.

    During this period, the virus can spread through close physical contact and contact with contaminated objects. Isolation is recommended for infected individuals until the contagious rash phase resolves fully to prevent transmission to others.​

    When Should You See a Doctor About Monkeypox Symptoms?

    Medical consultation is advised if someone develops a new or unexplained rash, especially if accompanied by fever, swollen lymph nodes, or flu-like symptoms and there is a possibility of exposure to mpox. Early diagnosis can be confirmed through laboratory testing of lesion samples.

    Healthcare providers may recommend supportive treatments to manage symptoms, since there is no universally approved cure for monkeypox. Vaccines and antiviral medications are available in some cases for prevention and treatment, particularly for those at higher risk or with severe disease. Prompt medical attention helps reduce complications and limits the spread of infection.​

    This updated view on monkeypox symptoms in 2026 underscores the importance of recognizing the full clinical spectrum, including the characteristic contagious rash and emerging signs. Public awareness and timely medical care remain critical to controlling mpox outbreaks and safeguarding community health.

    Frequently Asked Questions

    1. What vaccines are currently recommended for monkeypox prevention in 2026?

    Vaccination remains one of the most effective prevention measures against monkeypox. The JYNNEOS vaccine is widely recommended, especially for those at higher risk of exposure, with two doses administered four weeks apart for optimal protection. Some regions also use ACAM2000 and other vaccines authorized for outbreak response.​

    2. Can someone transmit monkeypox if they have no visible rash or symptoms?

    Yes, it is possible for infected individuals to transmit mpox virus before symptoms appear or even with very mild symptoms that go unnoticed. This asymptomatic or presymptomatic transmission underscores the importance of awareness and preventive measures such as vaccination and avoiding close contact with potentially infected individuals.​

    3. What hygiene practices help reduce the transmission of mpox?

    Frequent handwashing with soap and water or alcohol-based hand sanitizers is critical. Avoiding direct contact with lesions or contaminated materials, wearing masks in crowded or healthcare settings, and maintaining clean living environments are recommended to minimize the risk of exposure to the contagious rash and respiratory droplets.​

    4. How are healthcare settings managing infection control for monkeypox patients?

    Healthcare providers implement strict infection prevention and control protocols including the use of personal protective equipment (PPE), careful cleaning and disinfection of surfaces, proper handling of contaminated linens and waste, and isolation of patients until their contagious rash fully resolves. These measures help prevent secondary transmission in clinical settings.



    Source link